Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial.

Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. Circ Heart Fail. 2012 Sep 01; 5(5):571-8.

View in: PubMed

subject areas

Age Factors
Aged
Angiotensin II Type 1 Receptor Blockers
Biphenyl Compounds
Chi-Square Distribution
Comorbidity
Female
Health Status Disparities
Heart Failure
Hospitalization
Humans
Male
Middle Aged
Multivariate Analysis
Odds Ratio
Proportional Hazards Models
Risk Assessment
Risk Factors
Sex Factors
Stroke Volume
Tetrazoles
Time Factors
Treatment Outcome
Ventricular Function, Left

authors with profiles

Michael R. Zile